Literature DB >> 24804358

Racial disparities in hospitalizations, procedural treatments and mortality of patients hospitalized with atrial fibrillation.

Sahar Naderi, Fátima Rodriguez, Yun Wang, JoAnne M Foody.   

Abstract

OBJECTIVES: To explore racial differences in characteristics, procedural treatments, and mortality of hospitalized atrial fibrillation (AF) patients.
BACKGROUND: Despite a higher burden of AF risk factors, Black individuals have a lower prevalence of AF than their White counterparts. There is suggestion that AF may go undetected in minority groups, and there may be disparities in both diagnosis and treatment of AF.
METHODS: The study sample was drawn from the Healthcare Cost and Utilization Project database created by the Agency for Healthcare Research and Quality. Outcomes included AF hospitalization rate, in-hospital procedures performed, and in-hospital mortality within 6 defined sex-race subgroups: Black males, Black females, White males, White females, other males, and other females.
RESULTS: 165,319 hospitalizations (41% White male, 41% White female, 4% Black male, 4% Black female, 5% other male, 5% other female) with a primary discharge diagnosis of AF were identified. Black males and females were significantly younger than White patients and had more traditional and non-traditional risk factors. Black males and females were significantly less likely to have an ablation procedure or cardioversion than White males. Black race was an independent predictor of in-hospital mortality (Odds Ratio [95% CI] of 1.90 [1.5, 2.5] for Black males and 1.38 [1.1, 1.8] for Black females).
CONCLUSION: Using a large, contemporary sample of inpatients, we found significant racial differences in baseline characteristics, treatments, and outcomes of patients hospitalized with AF. There appear to be important racial disparities in the care of minorities who are hospitalized with AF that require further investigation.

Entities:  

Mesh:

Year:  2014        PMID: 24804358

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  14 in total

1.  Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation.

Authors:  Prashant D Bhave; Xin Lu; Saket Girotra; Hooman Kamel; Mary S Vaughan Sarrazin
Journal:  Heart Rhythm       Date:  2015-03-23       Impact factor: 6.343

2.  Effect of Digoxin Use Among Medicaid Enrollees With Atrial Fibrillation.

Authors:  Demilade Adedinsewo; Junjun Xu; Pradyumna Agasthi; Adesoji Oderinde; Oluwatoyosi Adekeye; Rajesh Sachdeva; George Rust; Anekwe Onwuanyi
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-05

3.  Impact of Race on Outcome of Patients Undergoing Rhythm Control of Atrial Fibrillation.

Authors:  Asad F Durrani; Siva Soma; Andrew D Althouse; George Leef; Dingxin Qin; Samir Saba
Journal:  J Immigr Minor Health       Date:  2018-02

Review 4.  Sex and Race/Ethnicity Differences in Atrial Fibrillation.

Authors:  Annabelle Santos Volgman; C Noel Bairey Merz; Emelia J Benjamin; Anne B Curtis; Margaret C Fang; Kathryn J Lindley; Carl J Pepine; Marmar Vaseghi; Albert L Waldo; Nanette K Wenger; Andrea M Russo
Journal:  J Am Coll Cardiol       Date:  2019-12-03       Impact factor: 24.094

5.  Racial Disparities in In-Hospital Adverse Events Among Patients With Atrial Fibrillation Implanted With a Watchman Left Atrial Appendage Occlusion Device: A US National Perspective.

Authors:  Muhammad Zia Khan; Muhammad Bilal Munir; Douglas Darden; Deepak Kumar Pasupula; Sudarshan Balla; Frederick T Han; Ryan Reeves; Jonathan C Hsu
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-04-28

6.  Effects of body mass index on risks for ischemic stroke, thromboembolism, and mortality in Chinese atrial fibrillation patients: a single-center experience.

Authors:  Hai-Jun Wang; Quan-Jin Si; Zhao-Liang Shan; Yu-Tao Guo; Kun Lin; Xiao-Ning Zhao; Yu-Tang Wang
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

7.  Demographic Differences in Catheter Ablation After Hospital Presentation With Symptomatic Atrial Fibrillation.

Authors:  Benjamin R Kummer; Prashant D Bhave; Alexander E Merkler; Gino Gialdini; Peter M Okin; Hooman Kamel
Journal:  J Am Heart Assoc       Date:  2015-09-22       Impact factor: 5.501

8.  Utilization and Predictors of Electrical Cardioversion in Patients Hospitalized for Atrial Fibrillation.

Authors:  Yogita M Rochlani; Nishi N Shah; Naga V Pothineni; Hakan Paydak
Journal:  Cardiol Res Pract       Date:  2016-02-07       Impact factor: 1.866

9.  Ablation Versus Drug Therapy for Atrial Fibrillation in Racial and Ethnic Minorities.

Authors:  Kevin L Thomas; Hussein R Al-Khalidi; Adam P Silverstein; Kristi H Monahan; Tristram D Bahnson; Jeanne E Poole; Daniel B Mark; Douglas L Packer
Journal:  J Am Coll Cardiol       Date:  2021-07-13       Impact factor: 27.203

10.  Feasibility Testing of the Alert for AFib Intervention.

Authors:  Pamela J McCabe; Kristin Vickers Douglas; Debra L Barton; Christine Austin; Adriana Delgado; Holli A DeVon
Journal:  West J Nurs Res       Date:  2016-07-11       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.